Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study
Condition:   Cervical Cancer Interventions:   Radiation: External beam radiotherapy (EBRT) + High-dose rate (HDR) Brachytherapy Experimental;   Radiation: External beam radiotherapy (EBRT) + High-dose rate (HDR) Brachytherapy Standard of Care;   Drug: Concurrent Chemotherapy Sponsors:   Lawson Health Research Institute;   Academic Medical Organization of Southwestern Ontario Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2020 Category: Research Source Type: clinical trials

Uveal Melanoma and Brachytheraphy: Long-term Outcomes.
Conditions:   106 Ruthenium Plaque Brachytherapy;   Uveal Melanoma Intervention:   Radiation: 106 Ruthenium plaque brachytherapy Sponsor:   Federico II University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2020 Category: Research Source Type: clinical trials

Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - September 18, 2020 Category: Cancer & Oncology Source Type: clinical trials

Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer
Condition:   Prostate Adenocarcinoma Intervention:   Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) Sponsor:   Alpha Tau Medical LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2020 Category: Research Source Type: clinical trials

Brachytherapy Innovations in Gynecologic Cancer
Condition:   Gynecologic Cancer Intervention:   Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer
Condition:   Prostatic Neoplasm Intervention:   Radiation: Real time High-Dose-Rate prostate brachytherapy in combination with stereotactic prostate radiotherapy Sponsor:   David Büchser Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2020 Category: Research Source Type: clinical trials